Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytotoxic chemotherapeutic agents target various molecules and pathways essential for rapid cell division. These include DNA (targeted by alkylating agents and cytotoxic antibiotics), enzymes involved in nucleotide synthesis (targeted by antimetabolites), topoisomerases I and II (targeted by topoisomerase inhibitors), and tubulin/microtubules (targeted by microtubule-targeting agents). This broad targeting underlies both their efficacy against various cancer types and their characteristic toxicities in normal, rapidly dividing tissues.
Disruption of genomic integrity, inhibition of nucleotide metabolism, interference with mitotic machinery
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple Targets of Cytotoxic Chemotherapy.